Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06899022 · ClinicalTrials.gov registry record · NA

Attention and Eye Movement in Parkinson's Disease

A NA study of Essential Tremor and Parkinson's Disease (PD), sponsored by University of Nebraska.

Recruiting
Registry status
NA
Development phase
138
Enrollment target
1
Study location

NCT06899022 is a NA study of Essential Tremor and Parkinson's Disease (PD) that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 138 participants, below the 399-participant average among 41 other Essential Tremor trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06899022, a NA study of Essential Tremor and Parkinson's Disease (PD), is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
NA
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational and interventional study is to understand how therapeutic deep brain stimulation (DBS) affects attention, perception and cognition in participants with Parkinson's disease (PD) and essential tremor (ET). The main questions it aims to answer are: * Does impaired control of attention and eye movement in PD alter how social cues are perceived and interpreted? * Does therapeutic DBS improve or worsen attentional and perceptual deficits for social cues in PD and ET? * Can DBS be optimized to restore normal attentional control in PD while remaining an effective therapy for other aspects of the disorder. * What do parts of the brain targeted by DBS contribute to the control of attention? Using an eye tracking camera, investigators will study how participants with PD and ET look at and perceive facial expressions of emotion before and after starting DBS therapy, in comparison to a group of healthy participants without ET, PD or DBS. Participants with PD and ET will see and rate morphed facial expressions on a computer screen in three conditions: * Before starting DBS therapy (over approximately 1 hour). * In the operating room, during the standard procedure to implant DBS electrodes, while the participant is awake (for no more than 15 minutes). * After starting DBS therapy, with brief experimental changes of DBS stimulation level and frequency (over approximately 1 hour).

Interventions

  • OTHER Normal therapeutic DBS
  • OTHER Reduced current DBS
  • OTHER Reduced frequency DBS

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2025-09-22
Est. Completion 2028-08
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT06899022

The ClinicalTrials.gov registry entry for NCT06899022 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 399-participant average among 41 other Essential Tremor trials with a reported enrollment target (65% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Essential Tremor appearing as the primary indexed condition, and to 3 interventions - of which Normal therapeutic DBS is the first listed.

NCT06899022 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT06899022 about?

NCT06899022 is a clinical study titled "Attention and Eye Movement in Parkinson's Disease". The goal of this observational and interventional study is to understand how therapeutic deep brain stimulation (DBS) affects attention, perception and cognition in participants with Parkinson's disease (PD) and essential tremor (ET). The main questions it aims to answer are: * Does impaired contro...

What is the current status of trial NCT06899022?

This trial is currently recruiting. It is a NA study. The enrollment target is 138 participants. The study started on 2025-09-22. Estimated completion is 2028-08.

What conditions does trial NCT06899022 study?

This clinical trial studies the following conditions: Essential Tremor, Parkinson's Disease (PD).

What interventions are being tested in trial NCT06899022?

The interventions under investigation include: Normal therapeutic DBS (OTHER), Reduced current DBS (OTHER), Reduced frequency DBS (OTHER).

Who is sponsoring clinical trial NCT06899022?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06899022 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Essential Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.